Large-scale testing (Phase 3)Study completedNCT03123627
What this trial is testing
Randomized Clinical Trial, Open, Multicenter Parallel, no Suspension Inferiority Prophylactic Treatment With Valganciclovir in Kidney Transplant CMV-seropositive Cellular Immunity to Develop CD8 + CMV-specific Treatment After Induction Thymoglobulin.
Who this might be right for
Kidney Transplant Infection
Maimónides Biomedical Research Institute of Córdoba 150